The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
What a ride and I get that long term holders and pure fundys won’t care but.....
Jan 21 = wave 1
Early feb =wave 2
Mid feb 120 to mid March 270 = wave 3 (5 sub waves)
Mid March to early April = wave 4
April to Mid May high 290ish = wave 5
Since May a horrible correction in “a” wave down “b” wave up in mid June and crash to “c” wave low of 160 (76% retracement).
Cutting it short the price is winding up for a big increase above the last high.
I think charty types will be getting in now.
Your maths looks bob on.
£86 a point puts you in control of 8600 shares with roughly a 5k margin
If you bought the shares instead at £2.30 that’s about £20k
In either case every point gained or lost moves you £86 give or take.
A quick weekend foray in fundy analysis which is obvious nonsense in my opinion.
Anyway I don’t think LFT market is like vaccine market. Once the best test is decided on it will get all the mone. Why use a test you know is slower, more uncomfortable and with less good at S&S. It’s why innova tests were bought by HMG last year. Crap but the best available. They didn’t get lots of different brands
One winner, the others will be nowhere.
Probably won’t make a difference to most of the board as I guess 95% are in profit but anyway.
Since the all time high in May, 190 has been an end of trading resistance point (August and October). Now the price has broken through 190 over last 7 days or so it should act as support or a trampoline.
I’d be surprised if price went below 190 now and may get a decent bounce tomorrow like a scalded cat back up.
Sleep well. Personally I won’t consider cashing out anything until at least 320.
Honestly I know most of you guys don’t like charts and that’s fine but the price today went from 180 to 222 hit the Fibonacci 62% retrace EXACTLY at 196 and is now on the way back up. So beautiful I want to cry ??
I think a well priced quick/self test with the best sensitivity and specificity ( S and S) will get all of the market. The results will not be a matter of opinion.
The governmental health and economic cost of a small reduction in percentage S and S will be too great.
All LFT manufacturing will likely use the same strip but maybe in different guises.
This gives LFT biotech the appearance of an all or nothing race with multiple runners. Once the winner emerges every other runner is nowhere.
Neutronic thanks for your link yesterday and thanks to all you good people for entertaining and informing.
The price is winding up for a big move tomorrow or Friday.
Wyndrum says a market is just buyers meeting sellers and agreeing a price. Right now the world is running out of AVCT sellers.
Love and respect to all Avacta analysts
Just to be clear. I don’t want people to sell the farm after reading a board post.
Rule #1 is protect your capital as much as possible and stay in the game but the charts are good and i hope investors enjoy the ride.
Lost nothing until you sell.